Activists cry foul over new HIV drug monopoly
The Economic Times | January 27, 2017
Doctors and aid organisations have called upon the Competition Commission of India and the price regulator to step in to ward off the monopoly over a new HIV drug, dolutegravir, which received the approval of the Indian drug controller last month.